Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

被引：18
作者：
Berenguer, Marina [2 ,3 ]
Charco, Ramon [4 ]
Manuel Pascasio, Juan [5 ]
Ignacio Herrero, Jose [1 ,2 ]
机构：
[1] Univ Navarra Clin, Liver Unit, Pamplona 31008, Spain
[2] CIBERehd, Valencia, Spain
[3] Hosp La Fe, Hepatol Unit, E-46009 Valencia, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, HBP Surg & Transplant Dept, E-08193 Barcelona, Spain
[5] Hosp Virgen del Rocio, Dept Digest Dis, Seville, Spain
来源：
LIVER INTERNATIONAL | 2012年 / 32卷 / 05期
关键词：
donor; immunosuppression; recurrence; survival; treatment; SUSTAINED VIROLOGICAL RESPONSE; CORTICOSTEROID-FREE IMMUNOSUPPRESSION; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; RABBIT ANTITHYMOCYTE GLOBULIN; PREEMPTIVE ANTIVIRAL THERAPY; PROSPECTIVE RANDOMIZED-TRIAL; RAPID-FIBROSIS-PROGRESSION; VENOUS-PRESSURE GRADIENT; RECURRENT HEPATITIS; PEGYLATED-INTERFERON;
D O I：
10.1111/j.1478-3231.2011.02731.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In November 2010, the Spanish Society of Liver Transplantation (Sociedad Espanola de Trasplante Hepatico, SETH) held a consensus conference. One of the topics of debate was liver transplantation in patients with hepatitis C. This document reviews (i) the natural history of post-transplant hepatitis C, (ii) factors associated with post-transplant prognosis in patients with hepatitis C, (iii) the role of immunosuppression in the evolution of recurrent hepatitis C and response to antiviral therapy, (iv) antiviral therapy, both before and after transplantation, (v) follow-up of patients with recurrent hepatitis C and (vi) the role of retransplantation.
引用
收藏
页码：712 / 731
页数：20
相关论文
共 219 条
  • [1] Evolution of liver transplantation in Europe: Report of the European liver transplant registry
    Adam, P
    McMaster, P
    O'Grady, JG
    Castaing, D
    Klempnauer, JL
    Jamieson, N
    Neuhaus, P
    Lerut, J
    Salizzoni, M
    Pollard, S
    Muhlbacher, F
    Rogiers, X
    Valdecasas, JCG
    Berenguer, J
    Jaeck, D
    Gonzalez, EM
    [J]. LIVER TRANSPLANTATION, 2003, 9 (12) : 1231 - 1243
  • [2] Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin
    Al-Hamoudi, Waleed
    Mohamed, Hazem
    Abaalkhail, Faisal
    Kamel, Yaser
    Al-Masri, Nasser
    Allam, Naglaa
    Alqahtani, Saleh
    Al-Sofayan, Mohammed
    Khalaf, Hatem
    Al-Sebayel, Mohammed
    Al-Jedai, Ahmed
    Abdo, Ayman
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) : 1848 - 1852
  • [3] Post-liver transplantation diabetes mellitus: An association with hepatitis C
    AlDosary, AA
    Ramji, AS
    Elliott, TG
    Sirrs, SM
    Thompson, DM
    Erb, SR
    Steinbrecher, UP
    Yoshida, EM
    [J]. LIVER TRANSPLANTATION, 2002, 8 (04) : 356 - 361
  • [4] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
    Angelico, Mario
    Petrolati, Alessandra
    Lionetti, Raffaella
    Lenci, Ilaria
    Burra, Patrizia
    Donato, Maria Francesca
    Merli, Manuela
    Strazzabosco, Mario
    Tisone, Giuseppe
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1009 - 1017
  • [5] The use of hepatitis C-infected grafts in liver transplantation
    Arenas, JI
    Vargas, HE
    Rakela, J
    [J]. LIVER TRANSPLANTATION, 2003, 9 (11) : S48 - S51
  • [6] The impact of sirolimus on hepatitis C recurrence after liver transplantation
    Asthana, Sonal
    Toso, Christian
    Meeberg, Glenda
    Bigam, David L.
    Mason, Andrew
    Shapiro, A. M. James
    Kneteman, Norman M.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 25 (01): : 28 - 34
  • [7] Decision for retransplantation of the liver - An experience- and cost-based analysis
    Azoulay, D
    Linhares, MM
    Huguet, E
    Delvart, V
    Castaing, D
    Adam, R
    Ichai, P
    Saliba, F
    Lemoine, A
    Samuel, D
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2002, 236 (06) : 713 - 721
  • [8] Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
    Babatin, M
    Schindel, L
    Burak, KW
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (06) : 359 - 365
  • [9] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
    Bacon, Bruce R.
    Gordon, Stuart C.
    Lawitz, Eric
    Marcellin, Patrick
    Vierling, John M.
    Zeuzem, Stefan
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Esteban, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1207 - 1217
  • [10] Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality
    Baid, S
    Cosimi, AB
    Farrell, ML
    Schoenfeld, DA
    Feng, S
    Chung, RT
    Tolkoff-Rubin, N
    Pascual, M
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1066 - 1072
12345678910